Investing where technology impacts most
Capricorn Partners is an independent European manager of venture capital and equity funds, investing in innovative European companies with technology as a competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and a broad industrial experience. Capricorn Partners is managing the venture capital funds Capricorn Sustainable Chemistry Fund, Capricorn Digital Growth Fund, Capricorn ICT Arkiv, Capricorn Health‐tech Fund, Capricorn Cleantech Fund, Capricorn Fusion China Fund and Capricorn Industrial Biotech Fund. In addition, it is the management company of Quest for Growth, quoted on Euronext Brussels, and the investment manager of Quest Cleantech Fund and Quest+, sub‐funds of Quest Management SICAV, registered in Luxembourg.
Venture Capital, Sustainable Chemistry, Cleantech, ICT, Health-tech, Quoted Securities, Asset Management, and Digital Growth
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Solvay Chemistry, Chemical Manufacturing | Solvay Chemistry, Chemical Manufacturing | Other 25 Mar 2023 | | |
Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 30 Jun 2024 | | |
Ageas Group Insurance | Ageas Group Insurance | Other 23 Nov 2023 | | |
UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 30 Sep 2022 | | |
The Faktory Fund Venture Capital and Private Equity Principals | The Faktory Fund Venture Capital and Private Equity Principals | Other 31 May 2022 | | |
Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 5 Dec 2022 | | |
imec Research Services | imec Research Services | Other 28 Feb 2023 | | |
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Sep 2022 | |